In the published article, an author name was incorrectly written as Kunlin Song. The correct spelling is Kunling Song.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
PTGR1, tumor metabolism, eicosanoid pathways, cancer therapeutics, inhibitor
Citation
Wang X, Yin G, Zhang W, Song K, Zhang L and Guo Z (2023) Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy. Front. Pharmacol. 14:1220144. doi: 10.3389/fphar.2023.1220144
Received
10 May 2023
Accepted
18 May 2023
Published
25 May 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2023
Updates
Copyright
© 2023 Wang, Yin, Zhang, Song, Zhang and Guo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guobing Yin, yinguobing@cqmu.edu.cn; Zufeng Guo, guozufeng@hotmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.